Previous FIP Digital Events

Catch up with all FIP previous webinars and digital events.

Impact of regulatory reliance on expanding global access to essential medicines

4 September 2023

Global collaboration of international health authorities is encouraged by WHO to ensure the safety, quality, and efficacy of locally registered medicinal products.
Strong regulatory systems for approving the marketing of medicinal products are a critical element of well-functioning health systems and important contributors to improving access and achieving universal health coverage.
Regulatory reliance is an effective way of regulating medical products through using global resources & financial investment more efficiently.
The implementation of Good regulatory Reliance practices (GRelP) on other regulators’ work promotes regulatory cooperation, convergence and transparency through networking and work-sharing.

- Mathew Cherian, Consultant - USA

- Nikolina Biskic, Global Regulatory Affairs Manager - Croatia

- Asmaa Khalil, Regulatory Affairs Manager - Egypt